Anjali Singh
Anjali Singh
Jamia Hamdard, Izon Science Ltd.
Verified email at
Cited by
Cited by
Nanomedicines as cancer therapeutics: current status
S Akhter, I Ahmad, MZ Ahmad, F Ramazani, A Singh, Z Rahman, ...
Current cancer drug targets 13 (4), 362-378, 2013
Nanocarrier based formulation of Thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies
A Singh, I Ahmad, S Akhter, GK Jain, Z Iqbal, S Talegaonkar, FJ Ahmad
Colloids and Surfaces B: Biointerfaces 102, 822-832, 2013
Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern
S Akhter, M Zaki Ahmad, A Singh, I Ahmad, M Rahman, M Anwar, ...
Current pharmaceutical design 17 (18), 1834-1850, 2011
In vitro and in vivo evaluation of Assam Bora rice starch-based bioadhesive microsphere as a drug carrier for colon targeting
MZ Ahmad, S Akhter, I Ahmad, A Singh, M Anwar, M Shamim, FJ Ahmad
Expert opinion on drug delivery 9 (2), 141-149, 2012
A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics
A Singh, I Ahmad, S Ahmad, Z Iqbal, FJ Ahmad
Drug development and industrial pharmacy 42 (9), 1524-1536, 2016
Thymoquinone: major molecular targets, prominent pharmacological actions and drug delivery concerns
A Singh, I Ahmad, S Akhter, M Zaki Ahmad, Z Iqbal, F J Ahmad
Current Bioactive Compounds 8 (4), 334-344, 2012
Feasibility of Assam Bora rice starch as a compression coat of 5-fluorouracil core tablet for colorectal cancer
M Zaki Ahmad, S Akhter, M Anwar, A Singh, I Ahmad, M Ruhal Ain, ...
Current drug delivery 9 (1), 105-110, 2012
Prognostic Significance of HER-2 and p53 Expression in Gallbladder Carcinoma in North Indian Patients
A Singh, PK Mishra, SS Saluja, MA Talikoti, P Kirtani, AK Najmi
Oncology 91 (6), 354-360, 2016
Phytochemical Nanomodification: Impending Perspectives
A Singh
The system can't perform the operation now. Try again later.
Articles 1–9